0001415889-23-008704.txt : 20230524
0001415889-23-008704.hdr.sgml : 20230524
20230524161225
ACCESSION NUMBER: 0001415889-23-008704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230522
FILED AS OF DATE: 20230524
DATE AS OF CHANGE: 20230524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reeve Emma
CENTRAL INDEX KEY: 0001680329
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 23954255
MAIL ADDRESS:
STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION
STREET 2: 195 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-05242023_080557.xml
X0407
4
2023-05-22
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001680329
Reeve Emma
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
true
false
false
false
1
Common Stock
2023-05-22
4
M
0
173
33.63
A
7373
D
Common Stock
2023-05-22
4
S
0
173
59.5242
D
7200
D
Common Stock
2023-05-22
4
M
0
2995
33.02
A
10195
D
Common Stock
2023-05-22
4
S
0
2995
59.5335
D
7200
D
Common Stock
2023-05-22
4
M
0
3948
33.63
A
11148
D
Common Stock
2023-05-22
4
S
0
3948
59.5313
D
7200
D
Common Stock
2023-05-23
4
M
0
157
33.63
A
7357
D
Common Stock
2023-05-23
4
S
0
157
59.5171
D
7200
D
Common Stock
2023-05-23
4
M
0
1093
33.02
A
8293
D
Common Stock
2023-05-23
4
S
0
1093
59.5320
D
7200
D
Common Stock
2023-05-23
4
M
0
1402
33.63
A
8602
D
Common Stock
2023-05-23
4
S
0
1402
59.5378
D
7200
D
Stock Option (Right to Buy)
33.63
2023-05-22
4
M
0
173
33.63
D
2028-12-13
Common Stock
173
994
D
Stock Option (Right to Buy)
33.02
2023-05-22
4
M
0
2995
33.02
D
2029-01-21
Common Stock
2995
8005
D
Stock Option (Right to Buy)
33.63
2023-05-22
4
M
0
3948
33.63
D
2028-12-13
Common Stock
3948
10052
D
Stock Option (Right to Buy)
33.63
2023-05-23
4
M
0
157
33.63
D
2028-12-13
Common Stock
157
837
D
Stock Option (Right to Buy)
33.02
2023-05-23
4
M
0
1093
33.02
D
2029-01-21
Common Stock
1093
6912
D
Stock Option (Right to Buy)
33.63
2023-05-23
4
M
0
1402
33.63
D
2028-12-13
Common Stock
1402
8650
D
Stock Option (Right to Buy)
51.16
2030-01-28
Common Stock
10000
10000
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
10000
10000
D
Stock Option (Right to Buy)
38.10
2032-01-06
Common Stock
12000
12000
D
Stock Option (Right to Buy)
39.42
2033-01-04
Common Stock
10000
10000
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-05-24